merck vaccines
Merck Vaccines is the vaccines division of Merck & Co., Inc., distributing 15 FDA-approved vaccines to US healthcare professionals through a dedicated direct-ordering portal at MerckVaccines.com.
- Company typePublic
- Founded1891
- HeadquartersRahway, United States
- Headcount—
- GTM typeB2B
- OfferingHardware or Manufacturing
What merck vaccines does
Merck Vaccines is the vaccines division of Merck & Co., Inc. (NYSE: MRK), a US-headquartered pharmaceutical company founded in 1891 and based in Rahway, New Jersey. The division operates MerckVaccines.com, a dedicated portal serving US healthcare professionals with product information, ordering functionality, and clinical resources. Its US portfolio comprises 15 vaccines addressing pneumococcal disease, HPV, measles, mumps, rubella, varicella, hepatitis A, hepatitis B, Haemophilus influenzae type b (Hib), rotavirus, and Ebola. Underlying technology spans four vaccine platforms: recombinant (e.g., GARDASIL), live attenuated (e.g., M-M-R II, VARIVAX), conjugate (e.g., CAPVAXIVE, VAXNEUVANCE), and inactivated, plus newer biologic modalities such as the RSV monoclonal antibody ENFLONSIA. Distribution runs through a direct-ordering platform and prime distributor partners, with select co-marketing arrangements (notably VAXELIS with Sanofi via the MSP Vaccine Company joint venture) and CDC alignment on US immunization schedules. Pricing is not publicly disclosed at the product level, and revenue and headcount are not reported at the division level, falling within Merck's consolidated pharmaceuticals segment reporting.
merck vaccines firmographics
Firmographics- Name
- merck vaccines
- Legal name
- Merck & Co., Inc.
- Website
- https://merckvaccines.com
- Company type
- Public
- Founded year
- 1891
- Operating status
- Operating
- Short description
- Merck Vaccines is the vaccines division of Merck & Co., Inc., distributing 15 FDA-approved vaccines to US healthcare professionals through a dedicated direct-ordering portal at MerckVaccines.com.
- Ownership category
- akta.pro rank
merck vaccines industry classification
Industry- Product category
- Human Vaccines
- NAICS
- Biological Product (except Diagnostic) Manufacturing (325414)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Prophylactic Human Vaccines (routine, pediatric, adult) (HLAAAEAA)
- akta.pro secondary industries
- Vaccine Ordering, Inventory Management & Cold-Chain Logistics (HLAJAHAF), Adult Vaccines (HLAIAEAB)
Keywords
Where merck vaccines is headquartered
LocationHeadquarters
- HQ city
- Rahway
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
merck vaccines business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure, Personnel
Go-to-market motion1 record
Distribution channels3 records
Marketing channels3 records
merck vaccines product offering
Product offeringCore offering
Merck Vaccines develops, manufactures, and distributes a portfolio of 15 FDA-approved human vaccines and one monoclonal antibody for the US market, sold to healthcare professionals through a dedicated direct-ordering portal. The portfolio spans pneumococcal disease, HPV, measles, mumps, rubella, varicella, hepatitis A and B, Haemophilus influenzae type b, rotavirus, tuberculosis, Ebola, and RSV prevention.
Product overview
Merck Vaccines is a comprehensive vaccine portfolio company offering 15 distinct vaccine products for healthcare professionals in the United States. The portfolio includes pediatric combination vaccines (VAXELIS hexavalent, ProQuad MMRV, M-M-R II), standalone pediatric vaccines (PedvaxHIB, RotaTeq, VARIVAX, RECOMBIVAX HB, VAQTA), adult/pneumococcal vaccines (CAPVAXIVE 21-valent, VAXNEUVANCE 15-valent, PNEUMOVAX 23), HPV prevention (GARDASIL 9), travel/epidemic vaccines (BCG, ERVEBO Ebola), and monoclonal antibody products (ENFLONSIA for RSV). The company operates MerckVaccines.com as a B2B ordering and information portal for healthcare providers, with sister sites for patient resources (Merck Connect), account management (My Merck Accounts), access support (Merck Access Program), and patient assistance (MerckHelps).
Differentiator
Problem solved
Functional benefit
Brands
- Merck Connect: Practical and patient-centered resources for health care professionals.
- My Merck Accounts
- Merck Access Program
- MerckHelps
Products and services
- CAPVAXIVE (Pneumococcal 21-valent Conjugate Vaccine) Pneumococcal 21-valent conjugate vaccine for protection against pneumococcal disease in adults, administered by healthcare professionals.
- GARDASIL 9 (Human Papillomavirus 9-valent Vaccine, Recombinant) 9-valent recombinant HPV vaccine for prevention of HPV-related cancers and diseases, administered to pediatric and adult patients by healthcare professionals.
- VAXNEUVANCE (Pneumococcal 15-valent Conjugate Vaccine) Pneumococcal 15-valent conjugate vaccine for pediatric and adult pneumococcal protection, administered by healthcare professionals.
- ENFLONSIA (clesrovimab-cfor) 105 mg injection Monoclonal antibody injection for respiratory syncytial virus (RSV) prevention, administered by healthcare professionals.
- ERVEBO (Ebola Zaire Vaccine, Live) Live attenuated vaccine for Ebola Zaire virus, administered by healthcare professionals for epidemic preparedness.
- M-M-R II (Measles, Mumps, and Rubella Virus Vaccine Live) Live attenuated combined vaccine for measles, mumps, and rubella immunization, administered by healthcare professionals.
- ProQuad (Measles, Mumps, Rubella and Varicella Virus Vaccine Live) Combined live attenuated vaccine for measles, mumps, rubella, and varicella (chickenpox), administered to pediatric patients by healthcare professionals.
- PedvaxHIB (Haemophilus b Conjugate Vaccine, Meningococcal Protein Conjugate) Haemophilus influenzae type b (Hib) conjugate vaccine using meningococcal protein conjugate technology for pediatric immunization.
- PNEUMOVAX 23 (Pneumococcal Vaccine Polyvalent) 23-valent pneumococcal vaccine for broad pneumococcal protection in adults, administered by healthcare professionals.
- RECOMBIVAX HB (Hepatitis B Vaccine, Recombinant) Recombinant hepatitis B vaccine for hepatitis B prevention, administered to pediatric and adult patients by healthcare professionals.
- RotaTeq (Rotavirus Vaccine, Live, Oral, Pentavalent) Oral live pentavalent rotavirus vaccine for rotavirus gastroenteritis prevention in infants, administered by healthcare professionals.
- VAQTA (Hepatitis A Vaccine, Inactivated) Inactivated hepatitis A vaccine for hepatitis A prevention, administered to pediatric and adult patients by healthcare professionals.
- VARIVAX (Varicella Virus Vaccine Live) Live attenuated varicella (chickenpox) vaccine for pediatric immunization, administered by healthcare professionals.
- VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) Hexavalent combination vaccine covering diphtheria, tetanus, pertussis, poliovirus, Haemophilus b, and hepatitis B for pediatric immunization; a trademark of MSP Vaccine Company distributed by Merck and Sanofi.
- BCG Vaccine U.S.P. Bacillus Calmette-Guérin (BCG) live attenuated vaccine for tuberculosis immunization, administered by healthcare professionals.
Companies that use merck vaccines
Customer profileSegments2 records
Ideal customer profiles2 records
merck vaccines technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
merck vaccines partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- SanoficoreVAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B Vaccine) is distributed by Merck and Sanofi for MSP Vaccine Company. VAXELIS is a trademark of MSP Vaccine Company.
- CDC (Centers for Disease Control and Prevention)coreMerckVaccines.com links to CDC resources including immunization schedules, Vaccines for Children program, and travelers health information for healthcare professionals.
Scale indicators2 records
Expansion highlights5 records
merck vaccines competitors and assessment
Company assessmentBroad incumbents
- Pfizer: Major Big Pharma competitor with the leading PCV franchise (Prevnar/Prevnar 20), HPV vaccine, and COVID-19 vaccine (Comirnaty) via BioNTech. Directly competes with Merck Vaccines across multiple respiratory and pediatric categories and operates a similar large-pharma distribution model to US healthcare professionals.
- GSK: Global vaccine leader (Shingrix, Bexsero, Cervarix historically, hepatitis, flu) competing head-to-head with Merck in shingles, HPV, and pediatric combination vaccines, with strong ex-US reach that contrasts with Merck Vaccines' US-only portal.
Direct peers
- Sanofi: Sanofi Pasteur is one of the world's largest vaccine franchises (flu, pediatric combinations, travel, RSV via nirsevimab/Beyfortus) and a direct co-marketing partner with Merck on VAXELIS, making it both ally and competitor across multiple categories.
- CSL Seqirus: Global influenza vaccine leader and broader specialty vaccines player (cell-based flu, pandemic preparedness) competing directly with Merck Vaccines in adult respiratory and public-health immunization channels.
- Emergent BioSolutions: Specialty vaccines and biologics company with travel/anthrax/smallpox portfolio, overlapping with Merck Vaccines in travel and select specialty indications and competing for similar US public-health and HCP channels.
Emerging players
- Moderna: mRNA platform company with approved COVID vaccine (Spikevax) and pipeline programs in RSV, flu, and pneumococcal disease that overlap directly with Merck Vaccines' franchises, representing a technology-driven competitive threat.
- Bavarian Nordic: Specialty vaccine company focused on smallpox/mpox (JYNNEOS) and travel/endemic disease vaccines, competing with Merck Vaccines in travel and bioterrorism/public-health preparedness segments.
- Dynavax Technologies: Vaccine adjuvants and hepatitis B vaccine (Heplisav-B) company competing with Merck Vaccines' RECOMBIVAX HB in the US adult hepatitis B market with a differentiated CpG adjuvant platform.
- Novavax: Protein-based vaccine developer with an approved COVID vaccine and pipeline programs in flu and RSV, using a recombinant nanoparticle platform that competes with Merck's traditional and mRNA-adjacent approaches.
- BioNTech: mRNA technology company partnering with Pfizer on Comirnaty and pursuing mRNA-based flu and other vaccines, representing a pipeline competitor to Merck Vaccines' respiratory and infectious disease franchises.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
merck vaccines financial estimates
Financial estimateRevenue estimate
Valuation estimate
merck vaccines leadership team
Management profileNumber of profiles
merck vaccines funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
merck vaccines M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about merck vaccines
What does merck vaccines do?
Merck Vaccines develops, manufactures, and distributes a portfolio of 15 FDA-approved human vaccines and one monoclonal antibody for the US market, sold to healthcare professionals through a dedicated direct-ordering portal. The portfolio spans pneumococcal disease, HPV, measles, mumps, rubella, varicella, hepatitis A and B, Haemophilus influenzae type b, rotavirus, tuberculosis, Ebola, and RSV prevention.
Is merck vaccines a public or private company?
merck vaccines is a public company. It is classified as public and is currently operating.
When was merck vaccines founded?
merck vaccines was founded in 1891.
Where is merck vaccines based?
merck vaccines is headquartered in Rahway, United States, in the North America region.
Who are merck vaccines's main competitors?
Broad incumbents on record are Pfizer and GSK. Direct peers are Sanofi, CSL Seqirus and Emergent BioSolutions. Emerging players are Moderna, Bavarian Nordic, Dynavax Technologies, Novavax and BioNTech.
Does merck vaccines have an API?
No public API is recorded for merck vaccines.
What industry is merck vaccines in?
merck vaccines's product category is Human Vaccines. Its primary akta.pro industry code is HLAAAEAA, Prophylactic Human Vaccines (routine, pediatric, adult), with a secondary code of HLAJAHAF, Vaccine Ordering, Inventory Management & Cold-Chain Logistics. Its NAICS code is 325414 and its SIC code is 2836.